Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Arshad Matin, a member of the Board of Directors at Everforth Inc (NASDAQ:EFOR), has increased his stake in the company through an open market transaction. On April 24, 2026, Matin acquired 10,000 shares of common stock for a total consideration of $193,462. This move comes at a time when the company is navigating a period of structural change and …
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) has seen significant insider activity following a substantial stock purchase by its Executive Chairman, Director, and ten percent owner, Vincent S. LoPriore. On April 21, 2026, Mr. LoPriore acquired common stock valued at $250,000 at a price point of $0.04 per share. This transaction highlights a notable i…
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) has seen notable insider activity following a period of leadership restructuring. Gary S. Stetz, who currently serves as both a director and the interim Chief Executive Officer, has acquired $50,000 worth of the company's common stock. This transaction, which was formally reported on April 21, 2026, involv…
Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) has seen notable insider activity following a significant stock purchase by one of its directors. Appajosyula Sireesh, serving as a Director for the company, executed a transaction on April 21, 2026, to increase his direct ownership in the firm. This move occurs during a period of organizational change, spe…
Nazar M. Khan, serving as Chief Technology Officer and Director at Terawulf Inc. (NASDAQ:WULF), has completed a series of transactions involving the acquisition and subsequent disposition of company shares. According to recent SEC Form 4 filings, these movements were tied to the vesting of performance-based restricted stock units (PSUs) that were t…
Recent regulatory filings reveal that Oasis Management Co Ltd., Oasis Investments II Master Fund Ltd., and Seth Fischer have reduced their positions in Stratus Properties Inc. (NASDAQ: STRS). The group, which identifies as 10% owners of the company, conducted a series of transactions between April 22 and April 24, 2026, resulting in total sales val…
Jun Cho, a member of the board of directors at Netlist Inc. (NASDAQ: NLST), has completed the sale of common stock totaling $41,600. According to recent filings with the Securities and Exchange Commission (SEC) via Form 4, the transactions took place over a two-day period in late April 2026. These sales were conducted under a Rule 10b5-1 trading pl…
Blake Welcher, a member of the Board of Directors for Netlist Inc. (NASDAQ: NLST), has completed a sale of common stock totaling $75,000. The transaction, which involved the disposal of 37,500 shares at a price point of $2.00 per share, took place on April 22, 2026. This divestment was executed under the framework of a Rule 10b5-1 trading plan that…
An SEC filing has revealed that Christopher Riley, the General Counsel and Secretary at Playboy, Inc. (NASDAQ: PLBY), completed a sale of company common stock on April 24, 2026. The transaction, which involved the disposal of 8,916 shares, resulted in total proceeds of $16,218. This specific movement of shares was not an open-market discretionary t…
Bernhard L. Kohn III, serving as President and CEO of Playboy, Inc. (NASDAQ: PLBY), has completed a sale of common stock totaling $33,784. The transaction occurred on April 24, 2026, involving the disposal of 18,502 shares. These shares were sold at market prices ranging from $1.795 to $1.87 per share.The purpose of this specific divestment was not…
Pacira BioSciences, Inc. (NASDAQ:PCRX) disclosed through a recent SEC filing that its Chief Financial Officer, Shawn Cross, conducted a series of stock transactions on April 23, 2026. The activity involved both the exercise of stock options and a subsequent sale of common stock, totaling $325,595 in proceeds from the disposal.The transaction sequen…
Michael Thawley, a director at Strategic Education, Inc. (NASDAQ: STRA), has increased his position in the company through a recent open market transaction. The purchase of 665 shares of common stock was completed on April 24, 2026, at a per-share price of $72.71, resulting in a total investment value of $48,352. This activity follows a separate gr…
Investment entities associated with Magnetar Financial LLC have significantly reduced their holdings in CoreWeave, Inc. (CRWV). On April 23, 2026, various funds linked to the firm disposed of approximately $36.2 million worth of Class A Common Stock. This transaction follows a period of high volatility for the company, which saw a massive 165% incr…
Entities associated with Magnetar have executed a significant reduction in their holdings of CoreWeave, Inc. (CRWV) Class A Common Stock. The series of transactions, totaling approximately $75.8 million, took place on April 22, 2026. These sales involved the disposal of 625,772 shares across multiple price points, reflecting a strategic movement by…
Recent regulatory filings have disclosed a significant divestment by a group of investment entities known as the Magnetar funds from CoreWeave, Inc. (CRWV). On April 22, 2026, these entities offloaded a substantial volume of Class A Common Stock, totaling approximately $104.7 million in value. This transaction occurred against a backdrop of recent …
Recent regulatory filings have revealed a substantial liquidation of CoreWeave, Inc. (NASDAQ: CRWV) equity by entities associated with Magnetar Financial LLC. On April 22, 2026, several affiliated parties, including Magnetar Capital Partners LP and Supernova Management LLC, along with David J. Snyderman, reported the sale of Class A Common Stock to…
A group of entities associated with I Squared Capital, which hold a ten percent ownership stake in Kinetik Holdings Inc. (NASDAQ: KNTK), have completed the sale of Class A Common Stock totaling approximately $7,714,019. The divestment occurred over two consecutive days in April 2026, involving multiple reporting persons including ISQ Global Fund II…
Synaptics Inc (NASDAQ: SYNA) President and Chief Executive Officer Rahul G. Patel has completed a sale of company stock. The transaction, which occurred on April 24, 2026, involved the disposal of 2,281 shares of common stock at a price point of $90.00 per share, resulting in total proceeds of $205,290.This divestment was conducted under the framew…
Daniel Joseph Apel, the Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), recently executed a sale of company stock totaling approximately $934,285. The transaction involved the disposal of 13,095 shares of common stock on April 22, 2026. These sales were conducted at weighted average prices ranging between $70.11 and $71.92…
James C. Hamilton, the Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), recently executed a sale of company stock totaling $750,000. The transaction, which involved 10,000 shares of common stock, took place on April 23, 2026. The shares were sold at price points ranging from $75.00 to $75.13 per share.This divestment occurre…
Jayshree Ullal, who serves as both the Chairperson and CEO of Arista Networks, Inc. (NASDAQ: ANET), has completed a significant disposal of company common stock. On April 22, 2026, Ms. Ullal sold holdings totaling approximately $75.9 million. This transaction was not an impromptu market move but was instead carried out under a Rule 10b5-1 trading p…
Julie Rubinstein, the President and Chief Operating Officer of Adaptive Biotechnologies Corp (NASDAQ: ADPT), has completed a series of stock transactions totaling approximately $798,423. The sales occurred over a three-day period in late April 2026. These disposals were conducted through a pre-arranged Rule 10b5-1 trading plan that Rubinstein had e…
Zivo Bioscience, Inc. (NASDAQ: ZIVO) has seen notable insider activity following a transaction by Mark E. Strome and affiliated entities. On April 17, 2026, an acquisition of 100,000 shares of common stock was completed for a total consideration of $200,000. This purchase was executed at a price point of $2.00 per share, which represents a signific…
RA Capital Healthcare Fund LP, an entity tied to RA Capital Management, L.P., has executed a sale of common stock in Vor Biopharma Inc. (NASDAQ: VOR). The transaction involved the disposal of 165,150 shares on April 22, 2026, generating proceeds of roughly $2,604,415. This movement comes as the biotechnology firm navigates a period of market fluctu…
In a notable move regarding internal equity holdings, Yousha Neman-Ebrahim, the Chief Clinical Officer of Neonc Technologies Holdings, Inc. (NASDAQ: NTHI), has executed a direct purchase of common stock. According to regulatory filings reported on April 23, 2026, Mr. Neman-Ebrahim acquired 500 shares at a price point of $4.88 per share, representin…
